| Q34335318 | 3'-orf and sor genes of human immunodeficiency virus: in vitro transcription-translation and immunoreactive domains |
| Q40428153 | A defective HIV-1 vector for gene transfer to human lymphocytes |
| Q41701218 | A defective proviral DNA with a 2.6-kb deletion of human immunodeficiency virus type 1 (HIV-1) in a persistently HIV-1 infected cell clone |
| Q34162178 | A second post-transcriptional trans-activator gene required for HTLV-III replication |
| Q45324625 | APOBEC Enzymes as Targets for Virus and Cancer Therapy. |
| Q36031782 | APOBEC3 versus Retroviruses, Immunity versus Invasion: Clash of the Titans |
| Q36827236 | APOBEC3G impairs the multimerization of the HIV-1 Vif protein in living cells |
| Q38334635 | Abrogation of Vif function by peptide derived from the N-terminal region of the human immunodeficiency virus type 1 (HIV-1) protease |
| Q39559552 | Advances in human retroviruses |
| Q37583529 | Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging |
| Q68505483 | Antibodies to recombinant HIV-1 vif, tat, and nef proteins in human sera |
| Q43641567 | Antigenic Domains of the HIV-1vifProtein as Recognized by Human Sera and Murine Monoclonal Antibodies |
| Q36650619 | Antisense phosphorothioate oligodeoxynucleotides targeted to the vpr gene inhibit human immunodeficiency virus type 1 replication in primary human macrophages |
| Q33604247 | Association of human immunodeficiency virus type 1 Vif with RNA and its role in reverse transcription |
| Q36687972 | Attenuation of human immunodeficiency virus type 1 cytopathic effect by a mutation affecting the transmembrane envelope glycoprotein |
| Q33834125 | Bioassay for trans-activation using purified human immunodeficiency virus tat-encoded protein: trans-activation requires mRNA synthesis |
| Q35851202 | Biological activity of human immunodeficiency virus type 1 Vif requires membrane targeting by C-terminal basic domains |
| Q41646425 | Biological characterization of human immunodeficiency virus type 1 and type 2 mutants in human peripheral blood mononuclear cells |
| Q39653639 | Cell surface effects of human immunodeficiency virus |
| Q40044520 | Cell-dependent requirement of human immunodeficiency virus type 1 Vif protein for maturation of virus particles. |
| Q43569851 | Characterization of human T-cell lines harboring defective human immunodeficiency virus type 1. |
| Q39870640 | Complementation of vif-defective human immunodeficiency virus type 1 by primate, but not nonprimate, lentivirus vif genes |
| Q35838106 | Conservation of an intact human immunodeficiency virus type 1 vif gene in vitro and in vivo |
| Q34069296 | Conservation of an intact vif gene of human immunodeficiency virus type 1 during maternal-fetal transmission |
| Q36629686 | Cysteine residues in the Vif protein of human immunodeficiency virus type 1 are essential for viral infectivity. |
| Q53437454 | Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. |
| Q74598041 | DNA inoculations with HIV-1 recombinant genomes that express cytokine genes enhance HIV-1 specific immune responses |
| Q33936492 | Effect of reciprocal complementation of two defective human immunodeficiency virus type 1 (HIV-1) molecular clones on HIV-1 cell tropism and virulence |
| Q33929164 | Effects of mutations within the 3' orf open reading frame region of human T-cell lymphotropic virus type III (HTLV-III/LAV) on replication and cytopathogenicity |
| Q36654022 | Efficiency of viral DNA synthesis during infection of permissive and nonpermissive cells with vif-negative human immunodeficiency virus type 1 |
| Q24644301 | Envelope glycoprotein and CD4 independence of vpu-facilitated human immunodeficiency virus type 1 capsid export |
| Q36810846 | Expression and biochemical characterization of human immunodeficiency virus type 1 nef gene product |
| Q42809144 | Expression of heterologous genes from an IRES translational cassette in replication competent murine leukemia virus vectors. |
| Q41671911 | Expression of human immunodeficiency virus type 1 vif and vpr mRNAs is rev-dependent and regulated by splicing |
| Q36885095 | Expression of the art gene protein of human T-lymphotropic virus type III (HTLV-III/LAV) in bacteria |
| Q40072060 | Function analysis of sequences in human APOBEC3G involved in Vif-mediated degradation. |
| Q28235487 | Functional analysis of the two cytidine deaminase domains in APOBEC3G |
| Q40728309 | Functional neutralization of HIV-1 Vif protein by intracellular immunization inhibits reverse transcription and viral replication |
| Q34288200 | Functional role of human immunodeficiency virus type 1 vpu. |
| Q40105638 | Generation and characterization of infectious chimeric clones between human immunodeficiency virus type 1 and simian immunodeficiency virus from an African green monkey |
| Q33639547 | Genetic variability between isolates of human immunodeficiency virus (HIV) type 2 is comparable to the variability among HIV type 1. |
| Q24619114 | HIV-1 Vif versus the APOBEC3 cytidine deaminases: an intracellular duel between pathogen and host restriction factors |
| Q34875979 | HIV-1 replication cycle |
| Q39549465 | Highly purified human immunodeficiency virus type 1 reveals a virtual absence of Vif in virions. |
| Q24563503 | Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication |
| Q41503378 | Human immunodeficiency virus Vpx is required for the early phase of replication in peripheral blood mononuclear cells |
| Q39880472 | Human immunodeficiency virus type 1 (HIV-1) protein Vif inhibits the activity of HIV-1 protease in bacteria and in vitro |
| Q40045880 | Human immunodeficiency virus type 1 DNA synthesis, integration, and efficient viral replication in growth-arrested T cells. |
| Q35873067 | Human immunodeficiency virus type 1 Vif does not influence expression or virion incorporation of gag-, pol-, and env-encoded proteins. |
| Q41704642 | Human immunodeficiency virus type 1vif, vpr, andvpu mutants can produce persistently infected cells |
| Q34055413 | Identification of a critical T(Q/D/E)x5ADx2(I/L) motif from primate lentivirus Vif proteins that regulate APOBEC3G and APOBEC3F neutralizing activity. |
| Q40926691 | Identification of a functionally important amino acid residue near to the amino-terminus of the human immunodeficiency virus type 1 Vif protein |
| Q34163678 | Identification of a protein encoded by the vpu gene of HIV-1. |
| Q24645417 | Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions |
| Q45848012 | Immunogenicity of human immunodeficiency virus (HIV) reverse transcriptase: detection of high levels of antibodies to HIV reverse transcriptase in sera of homosexual men. |
| Q42938709 | Immunological crossreactivity between the human immunodeficiency virus type 1 virion infectivity factor and a 170-kD surface antigen of Schistosoma mansoni. |
| Q33787335 | Importance of membrane fusion mediated by human immunodeficiency virus envelope glycoproteins for lysis of primary CD4-positive T cells |
| Q41897467 | Importance of the proline-rich multimerization domain on the oligomerization and nucleic acid binding properties of HIV-1 Vif |
| Q58379745 | In vitro infection of human epidermal Langerhans' cells with HIV-1 |
| Q28210666 | Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex |
| Q53534022 | Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein. |
| Q36959125 | Influence of primate lentiviral Vif and proteasome inhibitors on human immunodeficiency virus type 1 virion packaging of APOBEC3G. |
| Q35860937 | Inhibition of human and simian immunodeficiency virus protease function by targeting Vpx-protease-mutant fusion protein into viral particles |
| Q34348825 | Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by a two-amino-acid insertion in HIV-1 Vif from a nonprogressing mother and child |
| Q24669993 | Inhibition of tRNA₃(Lys)-primed reverse transcription by human APOBEC3G during human immunodeficiency virus type 1 replication |
| Q33815187 | Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics |
| Q37528880 | Kinetics of expression of multiply spliced RNA in early human immunodeficiency virus type 1 infection of lymphocytes and monocytes |
| Q36486841 | Lentiviral Vif: viral hijacker of the ubiquitin-proteasome system |
| Q34203154 | Mechanisms of infectivity and replication of HIV-1 and implications for therapy |
| Q39820667 | Molecular biology and pathogenesis of animal lentivirus infections. |
| Q37406352 | Molecular cloning and primary nucleotide sequence analysis of a distinct human immunodeficiency virus isolate reveal significant divergence in its genomic sequences |
| Q35855811 | Molecular determinants of acute single-cell lysis by human immunodeficiency virus type 1. |
| Q43767766 | Mutational analysis of human immunodeficiency virus type 1 vif gene |
| Q36800949 | Mutational analysis of the human immunodeficiency virus type 2 (HIV-2) genome in relation to HIV-1 and simian immunodeficiency virus SIV (AGM). |
| Q40116997 | Mutational analysis of the human immunodeficiency virus vpr open reading frame. |
| Q34603122 | Mutational analysis of the human immunodeficiency virus: the orf-B region down-regulates virus replication |
| Q36793690 | Open reading frame vpr of simian immunodeficiency virus encodes a virion-associated protein |
| Q39692591 | Pathogenesis of human immunodeficiency virus infection and prospects for control |
| Q38164170 | Pathogenesis of lentivirus infections |
| Q36804377 | Pattern of transcription of the genome of equine infectious anemia virus |
| Q41122204 | Prevalence of anti-vif antibodies in HIV-1 infected individuals assessed using recombinant baculovirus expressed vif protein |
| Q37950254 | Protein intrinsic disorder as a flexible armor and a weapon of HIV-1. |
| Q36820623 | Recombinational analysis of a natural noncytopathic human immunodeficiency virus type 1 (HIV-1) isolate: role of the vif gene in HIV-1 infection kinetics and cytopathicity. |
| Q35873743 | Role of Vif in human immunodeficiency virus type 1 reverse transcription |
| Q39597709 | Role of Vif in stability of the human immunodeficiency virus type 1 core |
| Q43894349 | Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity |
| Q36685112 | Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes |
| Q59098672 | SIV adaption to human cells |
| Q44966432 | Sequence analysis of HIV-1 vif gene in Spanish isolates. |
| Q33883514 | Small molecular compounds inhibit HIV-1 replication through specifically stabilizing APOBEC3G |
| Q39581553 | Strengths and weaknesses in methods for identifying the causative agent(s) of acquired immunodeficiency syndrome (AIDS). |
| Q90093309 | Structural perspectives on HIV-1 Vif and APOBEC3 restriction factor interactions |
| Q36626506 | Subcellular localization of the Vif protein of human immunodeficiency virus type 1. |
| Q38197389 | Targets for antiviral therapy of human immunodeficiency virus infection |
| Q26862780 | The APOBEC3 family of retroelement restriction factors |
| Q53033537 | The Antibody Response to the HIV-1 Specific "Out" (vpu) Protein: Identification of an Immunodominant Epitope and Correlation of Antibody Detectability to Clinical Stages |
| Q40467634 | The Human Immunodeficiency Virus Type 1 vif Gene: The Road from an Accessory to an Essential Role in Human Immunodeficiency Virus Type 1 Replication |
| Q36645938 | The RRE of human immunodeficiency virus type 1 contributes to cell-type-specific viral tropism |
| Q35888172 | The Vif and Gag proteins of human immunodeficiency virus type 1 colocalize in infected human T cells |
| Q35851966 | The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures. |
| Q36827056 | The art gene product of human immunodeficiency virus is required for replication |
| Q35854559 | The human immunodeficiency virus type 1 5' packaging signal structure affects translation but does not function as an internal ribosome entry site structure |
| Q35866134 | The human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein complexes |
| Q38366893 | The immunopathogenesis of HIV infection |
| Q40552660 | The interaction between HIV-1 Gag and APOBEC3G. |
| Q45878684 | The microepidemiology of wasting syndrome, a common link to diarrheal disease, cancer, rabies, animal models of AIDS, and HIV-AIDS YHAIDS). The feline leukemia virus and rabies virus models |
| Q35839334 | The vif gene is essential for efficient replication of caprine arthritis encephalitis virus in goat synovial membrane cells and affects the late steps of the virus replication cycle |
| Q28245841 | The vif gene of maedi-visna virus is essential for infectivity in vivo and in vitro |
| Q36651389 | Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells |
| Q33841920 | Vif is largely absent from human immunodeficiency virus type 1 mature virions and associates mainly with viral particles containing unprocessed gag. |
| Q35866177 | vif-negative human immunodeficiency virus type 1 persistently replicates in primary macrophages, producing attenuated progeny virus. |